Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SZUKF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SZUKF and 80,000+ other tickers.
See exactly how SZUKF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SZUKF and 80,000+ other tickers.
Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a global wholesaler of pharmaceutical products, with a strong presence both in Japan and internationally. The company's diverse activities are structured into four main divisions: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy Services, and Healthcare-Related Services. The Pharmaceutical Distribution segment focuses on sourcing a wide array of items, including prescription medications, diagnostic substances, various medical devices and supplies, and other health-focused goods directly from…
No recent news available.